Granite Investment Partners, LLC Cytosorbents Corp Transaction History

Granite Investment Partners, LLC

  • $2.32 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 10, 2020
SELL
$3.61 - $5.22 $116,815 - $168,913
-32,359 Closed
0 $0
Q2 2019

Aug 07, 2019
SELL
$5.92 - $7.78 $462,772 - $608,170
-78,171 Reduced 70.72%
32,359 $214,000
Q1 2019

May 13, 2019
BUY
$6.82 - $8.56 $352,450 - $442,372
51,679 Added 87.81%
110,530 $837,000
Q1 2018

May 04, 2018
BUY
$6.55 - $8.2 $385,474 - $482,578
58,851 New
58,851 $415,000

Others Institutions Holding CTSO

# of Institutions
55
Shares Held
16.9M
Call Options Held
10.1K
Put Options Held
500
View Full List

About Cytosorbents Corp

CTSO Quotes by TradingView
  • Ticker CTSO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 43,577,400
  • Market Cap $51.9M
  • Description
  • Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...
More about CTSO
Track This Portfolio

Track Granite Investment Partners, LLC Portfolio

Follow Granite Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email